Transactions
1
Insider / BOSTON SCIENTIFIC CORP
Mega Jessica L
Director at BOSTON SCIENTIFIC CORP
- Company
- BOSTON SCIENTIFIC CORP
- Ticker
- BSX
- First filing on record
- May 11, 2026
- Latest trade on record
- May 7, 2026
- SEC filings
- EDGAR ↗
Mega Jessica L, Director at BOSTON SCIENTIFIC CORP, has disclosed 1 transaction in BSX since May 11, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed May 11, 2026, 4 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
4.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Mega Jessica L reported 1 transaction that was neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 3,800 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| BSX | Other A | May 7, 2026 | May 11, 2026 | 4d | 3,800 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 11, 2026 | Form 4 | 0001225208-26-005109 | 1 | published | EDGAR ↗ |
Other insiders at BOSTON SCIENTIFIC CORP
- Mahoney Michael F Chairman, President & CEO 30 rows
- Butcher Arthur C EVP& Grp Pres, MedSurg & APAC 29 rows
- Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 28 rows
- O'Connor Padraig Andrew EVP, Global Operations 20 rows
- Monson Jonathan EVP and CFO 18 rows
- Woodworth Emily SVP, Global Controller and CAO 18 rows
- Brown Vance R EVP, GC and Corp. Secretary 16 rows
- O'Sullivan Miriam SVP, Chief HR Officer 15 rows
- Zane Ellen M Director 14 rows
- Smith Cathy R Director 11 rows
Everyone on file, with contracts and lobbying under the company's name: BOSTON SCIENTIFIC CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 1 | May 11, 2026 | May 11, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.